Magazine
ENEWS
SUBSCRIBE
WEBINARS
PODCASTS
EBOOKS
Edit submissions
Media kit
Innovation Awards
Home
Schering-Plough to pay $435 million, pleads guilty to charge of selling drugs for unapproved uses, overcharging Medicaid
Aug. 30, 2006
The company has just agreed to pay a
massive settlement for unapproved marketing and sales
. -AMS
pharmamanufacturing
The company has just agreed to pay a
massive settlement for unapproved marketing and sales
. -AMS
About the Author
pharmamanufacturing | pharmamanufacturing
Latest from Home
Michael Annino | Shutterstock-AI
Cell and gene therapy manufacturing challenges to persist in 2025
CDMO sector looks to recovery in 2025 amid positive macro, industry trends
Key drugs losing patent protection in 2025
Michael Annino / Shutterstock AI
Going above and beyond
Pittsburgh’s biotech leap
Michael Annino/Shutterstock AI
Pharma’s new age of longevity
Load More Content